Radiology, Vol 198, 225-231, Copyright © 1996 by Radiological Society of North America

ARTICLES

Detection of malignancies with SPECT versus PET, with 2-[fluorine- 18]fluoro-2-deoxy-D-glucose

WH Martin, D Delbeke, JA Patton and MP Sandler
Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN 37232-2675, USA.

PURPOSE: To compare single photon emission computed tomography (SPECT) with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) and positron emission tomography (PET) with FDG to evaluate malignancies. MATERIALS AND METHODS: PET and SPECT, with fluorine-18 sodium fluoride, were performed sequentially in a cylindric phantom that contained different size spheres with activity ratios of 5:1, 10:1, and 15:1. PET and SPECT were also performed in 24 patients with known or suspected malignancies. RESULTS: Sensitivities of PET and SPECT were 2,238 cpm/microCi (82.8 cpm/MBq) and 129 cpm/microCi (4.8 cpm/MBq), respectively (reconstructed spatial resolution, 7 and 17 mm, respectively [13-cm radius of rotation]). In the phantom studies, lesions of 1.5 and 1.3 cm or more in diameter were detected with a ratio of 5:1 and 10:1, respectively, and an information density of 150 counts per square centimeter. At FDG PET, 46 hypermetabolic lesions consistent with tumor were depicted in patients; at FDG SPECT, 36 (78%) were depicted. Sensitivity of FDG SPECT was 92% for detection of malignancies 1.8 cm or more in diameter seen at FDG PET. CONCLUSION: Findings at FDG SPECT can help differentiate benign from malignant lesions.

This article has been cited by other articles:

				H Zhang, M Tian, N Oriuchi, T Higuchi, S Tanada, and K Endo Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET Br. J. Radiol., May 31, 2002; 75(893): 409 - 416. [Abstract] [Full Text] [PDF]

				K. Higashi, Y. Ueda, T. Sakuma, H. Seki, M. Oguchi, M. Taniguchi, S. Taki, H. Tonami, S. Katsuda, and I. Yamamoto Comparison of [18F]FDG PET and 201Tl SPECT in Evaluation of Pulmonary Nodules J. Nucl. Med., October 1, 2001; 42(10): 1489 - 1496. [Abstract] [Full Text] [PDF]

				H. E. Daldrup-Link, C. Franzius, T. M. Link, D. Laukamp, J. Sciuk, H. Jurgens, O. Schober, and E. J. Rummeny Whole-Body MR Imaging for Detection of Bone Metastases in Children and Young Adults: Comparison with Skeletal Scintigraphy and FDG PET Am. J. Roentgenol., July 1, 2001; 177(1): 229 - 236. [Abstract] [Full Text] [PDF]

				M. K. Gould, C. C. Maclean, W. G. Kuschner, C. E. Rydzak, and D. K. Owens Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions: A Meta-analysis JAMA, February 21, 2001; 285(7): 914 - 924. [Abstract] [Full Text] [PDF]

				D. Delbeke, W. H. Martin, J. A. Patton, and M. P. Sandler Value of Iterative Reconstruction,AttenuationCorrection,and Image Fusion in the Interpretation of FDG PET Images with an Integrated Dual-Head Coincidence Camera and X-Ray-based Attenuation Maps Radiology, January 1, 2001; 218(1): 163 - 171. [Abstract] [Full Text]

				S. T. Mastin, W. E. Drane, E. M. Harman, J. J. Fenton, and L. Quesenberry FDG SPECT in Patients With Lung Masses Chest, April 1, 1999; 115(4): 1012 - 1017. [Abstract] [Full Text] [PDF]